Page 33 - Product Testing News Today

Press release content from Business Wire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Steba Biotech receives FDA Orphan Drug Designation for Padeliporfin ImPACT in Upper Tract ... Steba biotechMarch 8, 2021 GMT Designation confers advantages including marketing exclusivity and tax credits  Padeliporfin ImPACT pivotal Phase 3 trial in UTUC to start end Q1 2021 LUXEMBOURG, March 08, 2021 (GLOBE NEWSWIRE) -- Steba Biotech, the IMmune Photo Activate Cancer Treatment (IMPACT) specialist t...

Press release content from Business Wire. The AP news staff was not involved in its creation. Exelixis Enters into Exclusive License Agreement with WuXi Biologics to Support Further Expansion of its Growing Oncology Biologics Pipeline March 8, 2021 GMT ALAMEDA, Calif. & SHANGHAI--(BUSINESS WIRE)--Mar 8, 2021-- Exelixis, Inc. (Nasdaq: EXEL) and WuXi Biologics (“WuXi Bio”) (2269.HK) today announced the companies have entered into an exclusive license agreement to support the continued expansi...

Press release content from Business Wire. The AP news staff was not involved in its creation. Noveome Biotherapeutics, Inc. Makes New Appointment to Board of Directors March 8, 2021 GMT PITTSBURGH--(BUSINESS WIRE)--Mar 8, 2021-- Noveome Biotherapeutics, Inc., a clinical stage biopharmaceutical company focused on developing next-generation biologics for the restoration of cellular integrity of damaged tissues, has appointed Christopher J. P. Velis to the company’s Board of Directors. Mr. Velis...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 8, 2021--

Press release content from PR Newswire. The AP news staff was not involved in its creation. ADDF-Funded Investigators to Present Findings at Next Week’s Conference on Alzheimer’s & Parkinson’s Diseases (AD/PD 21) March 8, 2021 GMT (PRNewsfoto/ADDF) NEW YORK, March 8, 2021 /PRNewswire/ -- The Alzheimer’s Drug Discovery Foundation (ADDF) announced today that four of its funded researchers will be making presentations at the 15th International Conference on Alzheimer’s and Parkinson’s ...

Press release content from Accesswire. The AP news staff was not involved in its creation. Abivax Follows DSMB Recommendation to Stop the Phase 2b/3 miR-AGE Covid-19 Clinical Trial Due to Lack of Efficacy March 5, 2021 GMT The Data Safety and Monitoring Board (DSMB) confirmed ABX464 was safe and well tolerated in 383 high-risk Covid-19 patients Lower than expected rate (10.1%) of progression to severe disease or death with no difference between ABX464 and placebo groups Decision has no impact ...

Doctors take a microscopic craft loaded with cancer-killing chemicals, inject it into the human body, and drive it to a malignant tumor to deliver its payload before making a quick